Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 28-Feb 2022. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4945112011 | Product containing precisely acetylcysteine 150 milligram and taurine 500 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4945113018 | Acetylcysteine 150 mg and taurine 500 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5636311000052115 | acetylcystein 150 mg och taurin 500 mg, oral tablett | sv | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely acetylcysteine 150 milligram and taurine 500 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Oral tablet | true | Inferred relationship | Some | ||
Product containing precisely acetylcysteine 150 milligram and taurine 500 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
Product containing precisely acetylcysteine 150 milligram and taurine 500 milligram/1 each conventional release oral tablet (clinical drug) | Plays role | Mucolytic therapeutic role (role) | true | Inferred relationship | Some | ||
Product containing precisely acetylcysteine 150 milligram and taurine 500 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Taurine | true | Inferred relationship | Some | 1 | |
Product containing precisely acetylcysteine 150 milligram and taurine 500 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Taurine | true | Inferred relationship | Some | 1 | |
Product containing precisely acetylcysteine 150 milligram and taurine 500 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Product containing precisely acetylcysteine 150 milligram and taurine 500 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
Product containing precisely acetylcysteine 150 milligram and taurine 500 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Acetylcysteine (substance) | true | Inferred relationship | Some | 2 | |
Product containing precisely acetylcysteine 150 milligram and taurine 500 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Acetylcysteine (substance) | true | Inferred relationship | Some | 2 | |
Product containing precisely acetylcysteine 150 milligram and taurine 500 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Product containing precisely acetylcysteine 150 milligram and taurine 500 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
Product containing precisely acetylcysteine 150 milligram and taurine 500 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Acetylcysteine and taurine only product in oral dose form | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets